These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5604188)

  • 1. [Considerations on the exhaustibility of the regional fibrinolytic system of the limbs with repeated intraarterial administration of acetycholine in humans].
    Brunetti S; Tesi M; Biddau A; Caramelli L
    Riv Crit Clin Med; 1967 Oct; 67(5):376-85. PubMed ID: 5604188
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nicotinic acid and fibrinolysis in humans. I. Regional fibrinolysis (cerebral, of the upper extremity and of the lower extremity) caused by "arterial" administration of nicotinic acid].
    Tesi M
    Riv Crit Clin Med; 1967 Dec; 67(6):465-83. PubMed ID: 5603691
    [No Abstract]   [Full Text] [Related]  

  • 3. [Considerations on the activation of the regional fibrinolytic system of the extremities in subjects with obliterating arteriopathy with a malignant course].
    Brunetti S; Tesi M; Caramelli L
    Riv Crit Clin Med; 1967 Dec; 67(6):443-54. PubMed ID: 5603689
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blocking effect of atropine on fibrinolysis induced by acetylcholine and bradykinin].
    Tesi M; Brunetti S
    Riv Crit Clin Med; 1967 Aug; 67(3):256-70. PubMed ID: 5633534
    [No Abstract]   [Full Text] [Related]  

  • 5. [The influence of alpha-beta blocking agents on fibrinolysis induced by acetylcholine in humans].
    Brunetti S; Tesi M; Biddau A; Caramelli L
    Riv Crit Clin Med; 1967 Aug; 67(3):246-55. PubMed ID: 4395434
    [No Abstract]   [Full Text] [Related]  

  • 6. [Observations on the activation of the fibrinolytic system in regional circulation of the extremities by the use of the fibrinolytic test with acetylcholine].
    Andreotti L; Brunetti S; Tesi M
    Riv Crit Clin Med; 1966 Apr; 66(1):52-62. PubMed ID: 5989648
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Dec; 67(6):484-507. PubMed ID: 5603692
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of various drugs on the dynamics of fibrinolysis in humans].
    Brunetti S; Tesi M
    Riv Crit Clin Med; 1967 Aug; 67(3):233-45. PubMed ID: 5633715
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in activation of the fibrinolytic system in relation to age].
    Brunetti S; Tesi M; Caramelli L
    Riv Crit Clin Med; 1967 Dec; 67(6):455-64. PubMed ID: 5603690
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angiodynamic and fibrinolytic effect of eledoisin].
    Pratesi F; Tesi M; Brunetti S; Dabizzi RP; Caramelli L; Biddau A
    Actual Cardiol Angeiol Int (Paris); 1967; 16(4):319-25. PubMed ID: 5294005
    [No Abstract]   [Full Text] [Related]  

  • 11. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
    Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of selective stimulation of the alpha and beta adrenergic receptors on dynamic fibrinolysis in humans].
    Brunetti S; Tesi M; Biddau A; Caramelli L
    Riv Crit Clin Med; 1967 Oct; 67(5):386-94. PubMed ID: 5604189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Low molecular weight dextran and fibrinolysis in humans. I. Comparison between fibrinolysis activation by administering low molecular weight dextran by intravenous and intra-arterial routes].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Aug; 67(3):200-15. PubMed ID: 5633532
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activation of the fibrinolytic system following subcutaneous administration and inhalation of heparin].
    Psuja P; Tokarz A; Turowiecka Z; Sowier J; Zawilska K
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):105-8. PubMed ID: 8361902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intra-arterial infusion in the treatment of severe forms of occlusive vascular diseases of the lower limbs].
    Lytkin MI; Nazarov GD; Barinov VS
    Vestn Khir Im I I Grek; 1981 Jan; 126(1):78-82. PubMed ID: 7222426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
    Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
    Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In situ low-dose fibrinolysis in the treatment of ischemia of the limbs].
    Courtheoux P; Mercier V; Maiza D; Pelouze G; Khayat MC; Evrard C; Théron J
    Ann Radiol (Paris); 1984 Dec; 27(8):667-74. PubMed ID: 6529109
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intraarterial thrombolytic therapy in obliterative thromboangiitis of the lower extremities].
    Gervaziev VB; Kolobova OI
    Khirurgiia (Mosk); 1993 Feb; (2):26-32. PubMed ID: 8084146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does the intra-arterial administration of a drug increase its concentration in the extremities?].
    Widmer LK; Hürlimann F
    Z Kreislaufforsch; 1966 Apr; 55(4):410-7. PubMed ID: 5987079
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on vascular regulation in the extremities with special reference to arteriovenous shunts].
    Lofferer O; Mostbeck A; Partsch H
    Strahlentherapie Sonderb; 1968; 67():454-60. PubMed ID: 5719136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.